跳至主要内容
临床试验/ACTRN12609000588291
ACTRN12609000588291已完成未知

Safety and feasibilty study of new arterial closure device in patients following a Cardiac compared with literature controls for safety and time to haemostasis.

Cardiva Medical Inc0 个研究点目标入组 100 人开始时间: 2009年7月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • clinically scheduled for angiogram or angioplasty, able to ambulate >20 feet,

排除标准

  • current infection, femoral arteriotomy in <30 days, femoral arrter closure device in past 180 days, low platelets, high international normalised ratio (INR), anaemia, intra-procedural bleeding, high activated clotting time (ACT), A suspected intraluminal thrombus, hematoma, pseudo-aneurysm, or AV fistula of the target artery or 'multiple wall' arterial puncture.

研究者

相似试验